Nutritional safety and suitability of a specific protein hydrolysate derived from a whey protein concentrate and used in an infant formula and follow-on formula manufactured from hydrolysed protein by FrieslandCampina Nederland BV
The European Commission asked EFSA to deliver an opinion on the nutritional safety and suitability of a specific protein hydrolysate. It is derived from a whey protein concentrate and used in an infant and follow-on formula manufactured by FrieslandCampina Nederland B.V., which submitted a dossier to the European Commission to request an amendment of Regulation (EU) 2016/127 with respect to the protein sources that may be used in the manufacture of infant and/or follow-on formula. The protein hydrolysate under evaluation is sufficiently characterised with respect to the fraction of the hydroly... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2023 |
Verlag/Hrsg.: |
WILEY
|
Schlagwörter: | Science & Technology / Life Sciences & Biomedicine / Food Science & Technology / protein hydrolysate / characterisation / infant formula / follow-on formula / nutritional safety / suitability / clinical trial / GROWTH |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-29124978 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://discovery.ucl.ac.uk/id/eprint/10178579/1/Nutritional%20safety%20and%20suitability%20of%20a%20specific%20protein%20hydrolysate.pdf |